Home » Topics » Disease categories and therapies » Immune

Immune
RSS

Aquila receives milestone payment from SKB under Stimulon agreement

Jan. 30, 1998

Another SMART antibody advances to clinical testing

Jan. 30, 1998

Positive U.S. phase II results for Thymoglobulin in preventing kidney transplant rejection

Jan. 28, 1998

Chesapeake Biological Laboratories and LXR to codevelop Cardiosol products

Jan. 27, 1998

Nabi's Altastaph enters phase I/II

Jan. 26, 1998

Quilimmune-P enters phase II

Jan. 23, 1998

IL-12 offers new approach to BMT in leukemia patients

Jan. 20, 1998

MedImmune and SmithKline Beecham finalize vaccine agreement

Jan. 20, 1998

Cantab and Chemo-Sero to develop chickenpox and shingles vaccines

Jan. 19, 1998

Daclizumab efficacy demonstrated in transplant recipients

Jan. 16, 1998

Popular Stories

Today's news in brief
BioWorld
MMP inhibitors divulged in Accure Therapeutics patent
BioWorld Science
Accure Therapeutics has reported new oligopeptide derivatives acting as matrix metalloproteinase-2 (MMP-2) and MMP-9 inhibitors. As such, they are described as...
News in brief
BioWorld Asia
BioWorld Asia briefs for April 14, 2026
MSD discloses new HCN1/2 blockers
BioWorld Science
Merck Sharp & Dohme LLC (MSD) has synthesized new indazole derivatives acting as potassium/sodium hyperpolarization-activated cyclic nucleotide-gated channel 1...
Selective CBL-B inhibitor with improved safety profile disclosed
BioWorld Science
CBL-B is a RING-type E3 ubiquitin ligase that acts as a negative regulator of T-cell activation, contributing to immune homeostasis by limiting excessive immune...